XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 6 Months Ended
Jun. 28, 2023
May 26, 2023
May 23, 2023
May 12, 2023
Apr. 25, 2022
Mar. 21, 2022
Mar. 18, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 26, 2023
May 25, 2023
Dec. 31, 2022
Stockholders' Equity (Details) [Line Items]                        
Common stock shares             132,940     62,816,330    
Common stock shares issued and outstanding                   7,874,962    
Shares of common stock 3,125 1,989,676     43,750              
Gross proceed (in Dollars)               $ 96,000        
Net offering cost (in Dollars)   $ 6,400,000                    
Outstanding principal amount (in Dollars)           $ 9,200,000            
Common Stock, Shares, Outstanding               7,874,962       3,179,789
Stock Issued During Period, Value, Conversion of Units (in Dollars)   2,348,347             $ 91,757      
Sale Leaseback Transaction, Gross Proceeds, Financing Activities (in Dollars)   8,900,000                    
Net of debt issuance costs and discount (in Dollars)   7,900,000                    
Conversion of convertible notes (in Dollars)   $ 7,500,000 $ 7,500,000                  
Shares issued               14,612        
Interest accrued (in Dollars)               $ 388,000        
Common stock price per share (in Dollars per share)     $ 5.8     $ 29.6 $ 24.24          
Gross proceeds (in Dollars)             $ 3,300,000          
Interest expense (in Dollars)               $ 251,000        
Unsecured line of credit facility (in Dollars)           $ 10,000,000            
Shares of our common stock           12,500            
Market value of credit facility (in Dollars per share)           $ 24.24            
Common stock, warrant   156,712   187,500                
Maturity term of warrant   5 years   5 years                
Exercise price (in Dollars per share) $ 5.48                      
Options granted               78,125        
Minimum exercise price (in Dollars per share)               $ 2.64        
Maximum exercise price (in Dollars per share)               $ 5.48        
Stock option based compensation expense (in Dollars)               $ 1,900,000        
Unrecognized compensation costs (in Dollars)               $ 4,000,000        
Minimum [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Exercise price (in Dollars per share)       $ 3.164                
Maximum [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Exercise price (in Dollars per share)   $ 3.664                    
Common Stock [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Common stock shares               23,311        
Gross proceed (in Dollars)   $ 7,300,000                    
Shares issued               111,516        
Shares of our common stock                     7,983  
Chief Executive Officer [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Options granted               490,000        
Minimum exercise price (in Dollars per share)               $ 3.18        
Maximum exercise price (in Dollars per share)               $ 5.48        
Chief Technology Officer [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Options granted               62,500        
Minimum exercise price (in Dollars per share)               $ 2.64        
Maximum exercise price (in Dollars per share)               $ 5.48        
Note Investors [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Common stock shares               3,562        
Mr. Garchik [Member]                        
Stockholders' Equity (Details) [Line Items]                        
Outstanding principal amount (in Dollars)   $ 900,000                    
Common Stock, Shares, Outstanding   245,634